¾ËÆÄ À̹ÌÅÍ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø ¹æ»ç¼º ÇÙÁ¾ À¯Çüº°(¾Æ½ºÅ¸Æ¾, ¶óµã, ¾ÇƼ´½, ³³, ºñ½º¹«Æ®, ±âŸ), ÀÇ·á ¿ëµµº°, Áö¿ªº°, °æÀï ½ÃÀ庰(2020-2030³â)
Alpha Emitter Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Type of Radionuclide (Astatine, Radium, Actinium, Lead, Bismuth, Other), By Medical Application, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1692179
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,286,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,682,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,175,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾ËÆÄ À̹ÌÅÍ ¼¼°è ½ÃÀåÀº 2024³â 4¾ï 6,610¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â±îÁö ¿¬Æò±Õ 9.80%·Î ¿¹Ãø ±â°£ µ¿¾È °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¾ËÆÄ À̹ÌÅÍ ¼¼°è ½ÃÀåÀº ÇÙÀÇÇаú ¹æ»ç¼± Ä¡·á¶ó´Â ±¤¹üÀ§ÇÑ ºÐ¾ß Áß Àü¹® ºÐ¾ßÀÔ´Ï´Ù. ¾ËÆÄ ÀÔÀÚ¸¦ ¹æÃâÇÏ´Â ¹æ»ç¼º µ¿À§¿ø¼ÒÀÎ ¾ËÆÄ ¹æÃâ ÇÙÁ¾ÀÇ »ý»ê, À¯Åë, ÀÀ¿ëÀ» Áß½ÉÀ¸·Î Àü°³µË´Ï´Ù. ±× ¹è°æ¿¡´Â Áúº´ÀÇ È®»ê, ¾Ï ȯÀÚ Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹Á¦¾Ï¿¬±¸¼Ò(IARC)´Â 2040³â±îÁö Àü ¼¼°è ¾Ï ȯÀÚ ¼ö´Â 2,750¸¸ ¸íÀ¸·Î Áõ°¡Çϰí, ¾Ï °ü·Ã »ç¸ÁÀÚ ¼ö´Â 1,630¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¶ÇÇÑ, 2022³â 8¿ù Radiation Àú³Î¿¡ °ÔÀçµÈ ³í¹®¿¡¼­´Â ÀüÀ̼º °Å¼¼ ÀúÇ×¼º Àü¸³¼±¾Ï¿¡ ´ëÇÑ ¶óµã223 ¿ä¹ýÀÇ ÃÖÀû »ç¿ë¹ýÀ» ¸ð»öÇÏ´Â ÀϺ» ±Ù´ëÀÇ´ë °úÇÐÀÚµéÀÇ ¿¬±¸°¡ ¼Ò°³µÇ¾ú½À´Ï´Ù. ÀÌ ¿¬±¸´Â Ra-223ÀÇ Á¶±â Åõ¿©°¡ Àüü »ýÁ¸±â°£(OS)À» À¯ÀÇÇÏ°Ô °³¼±ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µÀ¸¸ç, »õ·Î¿î È£¸£¸ó ¿ä¹ýÀ̳ª Ç×¾ÏÁ¦ Ä¡·á Àü¿¡ Ra-223À» »ç¿ëÇÏ´Â °ÍÀÇ ÀáÀçÀû ÀÌÁ¡À» °­Á¶Çß½À´Ï´Ù. ¾ËÆÄ¼± ¹æÃâ ÇÙÁ¾Àº µ¶Æ¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ÀÇ·á, »ê¾÷, ¿¡³ÊÁö ºÐ¾ß¿¡¼­ °¢±¤À» ¹Þ°í ÀÖÀ¸¸ç, ½ÃÀåÀº °ý¸ñÇÒ¸¸ÇÑ ¼ºÀå°ú Çõ½ÅÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ¾ç¼ºÀÚ 2°³¿Í Áß¼ºÀÚ 2°³·Î ±¸¼ºµÈ ¾ËÆÄ ÀÔÀÚ°¡ ¹æÃâµÇ±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ ÀÔÀÚ´Â ³ôÀº ÀüÇϸ¦ ¶ì°í Á¶Á÷ ³» ºñÇà°Å¸®°¡ ª¾Æ ±¹¼Ò Ä¡·á¿¡ È¿°úÀûÀÔ´Ï´Ù. ¾ËÆÄ¼±Àº °­·ÂÇÏ¿© ÁÖº¯ÀÇ °Ç°­ÇÑ Á¶Á÷À» º¸Á¸Çϸ鼭 Á¤È®ÇÏ°Ô ¾Ï¼¼Æ÷¿¡ ¼Õ»óÀ» ÀÔÇô ÆÄ±«ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð(2024³â) 4¾ï 6,610¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð(2030³â) 8¾ï 1,037¸¸ ´Þ·¯
CAGR(2025-2030³â) 9.80%
±Þ¼ºÀå ºÎ¹® ³­¼Ò¾Ï
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÇÙÀÇÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÁÖ¿ä ½ÃÀå À̽´

±ÔÁ¦»óÀÇ Àå¾Ö¹°

ÁÖ¿ä ½ÃÀå µ¿Çâ

Ç¥Àû ¥á ÀÔÀÚ Ä¡·áÀÇ ¹ßÀü:

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦11Àå 2°³ °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ¾ËÆÄ À̹ÌÅÍ ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Alpha Emitter Market Was valued at USD 466.10 million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.80% through 2030. The Global Alpha Emitter Market is a specialized sector within the broader field of nuclear medicine and radiation therapy. It revolves around the production, distribution, and application of alpha-emitting radionuclides, which are radioactive isotopes emitting alpha particles. This is ascribed due to the growing disease prevalence, growing cancer cases, rising aging population, etc. For instance, the International Agency for Research on Cancer (IARC) projects that by 2040, the global cancer burden will rise to 27.5 million new cases and 16.3 million cancer-related deaths, largely due to population growth and aging. Additionally, an August 2022 article in the Radiation journal featured research by a Kindai University scientist in Japan exploring the optimal use of Radium-223 therapy for Metastatic Castration-Resistant Prostate Cancer. The study indicated that early administration of Ra-223 significantly improved overall survival (OS), highlighting potential advantages of using Ra-223 before novel hormonal or anticancer treatments. Alpha emitters have gained prominence in medical, industrial, and energy sectors due to their unique characteristics, and the market is experiencing notable growth and innovation. Due to the release of alpha particles, which consist of two protons and two neutrons. These particles are highly charged and have a short range in tissue, making them effective for localized therapy. Alpha radiation is potent, capable of damaging and destroying cancer cells with precision while sparing nearby healthy tissue.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 466.10 Million
Market Size 2030USD 810.37 Million
CAGR 2025-20309.80%
Fastest Growing SegmentOvarian Cancer
Largest MarketNorth America

Key Market Drivers

Growing Demand for Nuclear Medicine

One of the primary drivers of the Global Alpha Emitter Market is the increasing demand for nuclear medicine. Advances in medical science have revealed the efficacy of alpha emitters in targeted cancer therapy. Alpha particles are highly effective at killing cancer cells, making them a vital component of radiopharmaceuticals used in cancer treatment. The shift towards precision medicine is another key reason for the growing demand. Medical professionals are increasingly tailoring treatments to individual patients, and alpha emitters offer a precise way to target cancerous cells while minimizing damage to healthy tissue. The global rise in cancer cases is a significant driver. As cancer incidence continues to increase, the demand for effective treatment options also grows. Alpha emitters provide a promising solution for certain types of cancers that are challenging to treat through conventional methods. Ongoing clinical trials and research efforts are further fueling demand. Pharmaceutical companies and research institutions are investing heavily in the development of new alpha-emitting radiopharmaceuticals, expanding the range of treatable conditions. Increasing patient awareness and advocacy groups' efforts have contributed to the demand for nuclear medicine. Patients and their families are seeking out cutting-edge treatments, and alpha emitter-based therapies are becoming more accessible and sought after.

Key Market Challenges

Regulatory Hurdles

Regulatory hurdles, such as stringent licensing and safety regulations, can significantly impede the growth of the Global Alpha Emitter Market. Governments and regulatory bodies closely monitor the use and transport of radioactive materials, including alpha emitters, due to safety concerns. This leads to lengthy approval processes and strict compliance requirements. The highly radioactive nature of alpha emitters necessitates rigorous oversight to prevent accidents and ensure public safety. However, the complexity and stringency of regulatory processes can slow down the development and commercialization of alpha-emitting products. Companies may face delays and increased costs in navigating the regulatory landscape, hindering market growth.

Key Market Trends

Advancements in Targeted Alpha-Particle Therapy:

A significant trend in the Global Alpha Emitter Market is the continuous advancements in targeted alpha-particle therapy. This therapy involves the use of alpha-emitting radiopharmaceuticals to precisely target and destroy cancer cells while sparing healthy tissue. Recent research and development efforts have led to the creation of novel alpha-emitting compounds that are more effective and have reduced side effects. This trend is driven by the increasing focus on personalized medicine in oncology. Healthcare providers and pharmaceutical companies are investing in research to develop alpha emitters that can be tailored to a patient's specific cancer type and genetic profile. As a result, targeted alpha-particle therapy is gaining prominence as a promising and minimally invasive treatment option for various cancers, including prostate, bone, and pancreatic cancer.

Key Market Players

Report Scope:

In this report, the Global Alpha Emitter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Alpha Emitter Market, By Type of Radionuclide:

Alpha Emitter Market, By Medical Application:

Alpha Emitter Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alpha Emitter Market.

Available Customizations:

Global Alpha Emitter market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Alpha Emitter Market Outlook

6. North America Alpha Emitter Market Outlook

7. Europe Alpha Emitter Market Outlook

8. Asia-Pacific Alpha Emitter Market Outlook

9. South America Alpha Emitter Market Outlook

10. Middle East and Africa Alpha Emitter Market Outlook

11. Market Dynamics

11.2 Challenges

12. Market Trends & Developments

13. Global Alpha Emitter Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â